Neuropathic ocular surface pain: Emerging drug targets and therapeutic implications.

ABSTRACT:

Introduction

Dysfunction at various levels of the somatosensory system can lead to ocular surface pain with a neuropathic component. Compared to nociceptive pain (due to noxious stimuli at the ocular surface), neuropathic pain tends to be chronic and refractory to therapies, making it an important source of morbidity in the population. An understanding of the options available for neuropathic ocular surface pain, including new and emerging therapies, is thus an important topic.

Areas covered

This review will examine studies focusing on ocular surface pain, emphasizing those examining patients with a neuropathic component. Attention will be placed toward recent (after 2017) studies that have examined new and emerging therapies for neuropathic ocular surface pain.

Expert op

SUBMITTER: Patel S 

PROVIDER: S-EPMC9613591 | biostudies-literature | 2022 Aug

REPOSITORIES: biostudies-literature